Labcorp Holdings Inc.

NYSE:LH

Medical - Diagnostics & Research

Healthcare
$370.78 -1.33%

-$3.46 today

Market cap
$30.11B
Beta
0.88
P/E (TTM)
22.4
EPS (TTM)
$11.44
Dividend yield
1.12%
52W Low $241.81High $293.72

Volume 0.69M

Average 0.63M

LH Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Labcorp Holdings Inc.NYSE: LH

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin holds steady near 29.8%

Gross margin was 29.8% in Q2 FY2026, up 0.1 pp from a year earlier. On a trailing-twelve-month basis it was 27.8%, down 0.3 pp year over year. Over 3 fiscal years it narrowed by 4.5 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
29.8%+3.3 pp QoQ
Last fiscal yearDec 2025
26.8%-1.1 pp YoY
LTMJun 2026
27.8%-0.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.1 pp——
1 year-1.1 pp——
3 years-4.5 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
26.8%
Year-over-year change
-1.1pp

Gross Margin vs competitors

How LH compares with its peers on the latest reported figures

  • LH's LTM Jun 2026 gross margin of 27.8% is the 6th highest of the 7 companies compared; the peer median is 51.6%.
  • Its year-over-year change of -0.3 pp is the 6th highest of 7, against a peer median of +1.2 pp.
  • Over three fiscal years its change of -4.5 pp compares with a peer median of -1.1 pp.
LH Competitors Peer median
Gross Margin for LH and competitors
Company Period LTM level YoY 3-year change
NTRANatera, Inc.LTM Jun 202665.3% +2.4 pp+20.5 pp
GHGuardant Health, Inc.LTM Sep 202665.2% +1.4 pp-0.8 pp
QGENQiagen N.V.LTM Jun 202661.8% -1.1 pp-2.9 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202641.4% +1.0 pp-1.4 pp
DGXQuest Diagnostics IncorporatedLTM Sep 202633.1% -0.2 pp-2.8 pp
LHLabcorp Holdings Inc.LTM Jun 202627.8% -0.3 pp-4.5 pp
GRALGRAIL, Inc.LTM Jun 2026-10.8% +45.7 pp+167.1 pp
Peer median (excluding LH) 51.6%+1.2 pp-1.1 pp

Competitors are the stored peer set for LH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue13.14B11.86B12.16B13.01B13.95B
Cost of Revenue8.14B8.16B8.8B9.38B10.22B
Gross Profit4.99B3.71B3.36B3.62B3.73B
Gross Margin38.0%31.3%27.7%27.9%26.8%
Research & Development002M00
Selling, General & Admin1.69B2B2.02B2.23B2.22B
Operating Expenses1.94B2.27B2.64B2.54B2.22B
Depreciation & Amortization577M537.2M577.3M643.5M681.1M
EBITDA3.68B1.95B1.35B1.81B2.01B
EBITDA Margin28.0%16.5%11.1%13.9%14.4%
Operating Income3.05B1.44B725.6M1.09B1.52B
Operating Margin23.2%12.1%6.0%8.4%10.9%
Interest Income000015.2M
Interest Expense211.8M179.8M199.6M208.3M224.1M
Other Income / Expenses(161M)(199.1M)(156.7M)(127.2M)(408.7M)
Income Before Tax2.89B1.24B568.9M959.5M1.11B
Pre-Tax Margin22.0%10.4%4.7%7.4%7.9%
Income Tax Expense690M233.9M188.5M212.4M229.8M
Net Income2.38B1.28B418M746M876.5M
Net Margin18.1%10.8%3.4%5.7%6.3%
EPS (Basic)24.5814.044.808.8910.54
EPS (Diluted)24.3813.964.778.8410.46
Weighted Avg Shares96.7M91.1M87.1M83.9M83.2M
Weighted Avg Shares (Diluted)97.5M91.6M87.6M84.4M83.8M

Labcorp Holdings Inc.

NYSE:LH

Intrinsic Alpha fair value

Locked

Current Price

$370.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.